Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06971627

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

Led by Istanbul University - Cerrahpasa · Updated on 2025-05-14

120

Participants Needed

1

Research Sites

57 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.

CONDITIONS

Official Title

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals aged 18 years or older
  • Able to read and write in Turkish
  • Diagnosed with inflammatory bowel disease (IBD) for at least 6 months
  • In clinical remission (Harvey-Bradshaw Index score < 5 or Simple Clinical Colitis Activity Index score < 3)
  • Able to use a smartphone
  • Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address
  • Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom)
  • Willing to participate in the study voluntarily
Not Eligible

You will not qualify if you...

  • Diagnosed with any psychiatric or cognitive disorder
  • Having any condition that impairs communication
  • Pregnant women
  • Patients receiving infusion-based treatment
  • Having an advanced chronic disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology

Istanbul, Turkey (Türkiye), 34098

Actively Recruiting

Loading map...

Research Team

K

Kimya Kılıçaslan, PhD Candidate

CONTACT

Z

Zeliha Tulek, PhD, Prof.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here